ARTERIAL HYPERTENSION AMONG INDIVIDUALS OF 25–64 YEARS OLD: PREVALENCE, AWARENESS, TREATMENT AND CONTROL. BY THE DATA FROM ECCD
https://doi.org/10.15829/1728-8800-2014-4-4-14
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Full Text:
Abstract
Aim. To study prevalence of arterial hypertension (AH), mean values of systolic and diastolic blood pressure (SBP, DBP), awareness of patients about their disease, medication consumption (MC) and efficacy of treatment in several regions of Russia.
Material and methods. Representative selections were made in 9 regions of Russia: men (n=5563), women (n=9737) of 25–64 y.o., studied in 2012–2013 with the response 80%. Systematic stratified multilevel random selection was formed with localilty criteria (Kisch method). The Questionnaire on the presence of AH included: awareness of the patient about his disease, drug intake. BP measurement was performed on the right arm by automatic tonometer Omron in sitting position after 5 minutes resting. The mean value of two measurements was used. BP defined as SBP ≥140 mmHg, DBP ≥90 mmHg, or if the patient had taken antihypertensive therapy. Efficacy of treatment — the part of patients (in %) who reached target BP. Control group — part of patients (in %) with BP <140/90 mmHg. Statistic data calculation was done with computer-based statistic software — SAS with standardising by age stratification of Europe.
Results. Mean SBP and DBP were 130,7±0,1 mmHg and 81,6±0,1 mmHg respectively. Prevalence of AH — 44%, higher in men (p<0,001). Prevalence of AH was higher in rural area citizens in men — 51,8% vs 47,5% (р<0,02) and in women — 42,9% vs 40,2% (р<0,05). Awareness was 67,5% in men, 78,9% in women. Medications were taken by 60,9% of women and 39,5% of men. Effectively treated were 53,5% of women and 41,4% of men. With the age the part of effectively treated decreases (p<0,0005). BP is under control only in 1/3 of women and 14,4% of men.
Conclusion. The role of AH as one of the main modifiable risk factors of cardiovascular diseases is proved, however it is depressing that the percent of controlled AH is low. BP control is the main task of outpatient surveillance at every local outpatient department, where now less than a half of those affected are being observed.
About the Authors
S. A. BoytsovRussian Federation
Yu. A. Balanova
Russian Federation
tel.: 8 (926) 126–76–91
S. A. Shalnova
Russian Federation
A. D. Deev
Russian Federation
G. V. Artamonova
Russian Federation
T. M. Gatagonova
Russian Federation
D. V. Duplyakov
Russian Federation
A. Yu. Efanov
Russian Federation
Yu. V. Zhernakova
Russian Federation
A. O. Konradi
Russian Federation
R. A. Libis
Russian Federation
A. V. Minakov
Russian Federation
S. V. Nedogoda
Russian Federation
E. V. Oshchepkova
Russian Federation
S. A. Romanchuk
Russian Federation
O. P. Rotar
Russian Federation
I. A. Trubacheva
Russian Federation
I. E. Chazova
Russian Federation
E. V. Shlyakhto
Russian Federation
G. A. Muromtseva
Russian Federation
S. E. Evstifeeva
Russian Federation
A. V. Kapustina
Russian Federation
V. V. Konstantinov
Russian Federation
R. G. Oganov
Russian Federation
M. N. Mamedov
Russian Federation
E. I. Baranova
Russian Federation
кафедра факультетской терапии,
Санкт-Петербург
O. A. Nazarova
Russian Federation
O. A. Shutemova
Russian Federation
G. I. Furmenko
Russian Federation
N. I. Babenko
Russian Federation
O. G. Azarin
Russian Federation
L. V. Bondartsov
Russian Federation
A. E. Khvostikova
Russian Federation
A. A. Ledyaeva
Russian Federation
E. V. Chumachek
Russian Federation
E. N. Isaeva
Russian Federation
I. R. Basyrova
Russian Federation
V. Yu. Kondratenko
Russian Federation
E. A. Lopina
Russian Federation
D. V. Safonova
Russian Federation
A. E. Skripchenko
Russian Federation
E. V. Indukaeva
Russian Federation
N. V. Cherkass
Russian Federation
S. A. Maksimov
Russian Federation
Ya. V. Danilchenko
Russian Federation
T. A. Mulerova
S. V. Shalaev
I. V. Medvedeva
V. G. Shava
M. A. Storozhok
G. V. Tolparov
Z. T. Astakhova
Z. A. Toguzova
V. S. Kaveshnikov
R. S. Karpov
V. N. Serebryakova
References
1. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360, Issue 9349: 1903-13.
2. Ford ES, Ajani UA, Croft JB, et al. Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980-2000. The New England Journal of Medicine, 2007, 356; 237, p 2388-98.
3. Lawes CM, Hoorn SV, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet 2008; 371; Issue 9623: 1513-8.
4. Vorobjeva OD, Denisenko MB, Elizarov VV, et al. The Demographic Yearbook of Russia. 2013: Statistical Handbook. Rosstat.- M. 2013; 543 pp. Russian (Vorob'eva O.D., Denisenko M.B., Elizarov V.V. i dr. Demograficheskii ezhegodnik Rossii, Stat.sb. Rosstat. M 2013; 543 c. http://www.gks.ru).
5. Kearney P, Whelton M, Reynolds K, et al. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004; 22: 11-9.
6. Chow SK, Teo KK, Rangarajan S, et al. Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and LowIncome Countries. JAMA 2013; 310 (9): 959-68.
7. Falaschetti E, Chaudhury M, Mindell J, et al. Continued Improvement in Hypertension Management in England: Results From the Health Survey for England 2006. Hypertension 2009; 53: 480-6.
8. Kish L. Survey Sampling, New York: John Wiley and Sons, 1965.
9. Scientific Organizing Committee of the ESSE-RF. Epidemiology of cardiovascular diseases in different regions of Russia (ESSE-RF). The rationale for and design of the study. Preventive Medicine 2013; 6: 25-34. Russian (Nauchno-organizatsionnyi komitet proekta ESSE-RF Epidemiologiya serdechno-sosudistykh zabolevanii v razlichnykh regionakh Rossii (ESSE-RF). Obosnovanie i dizain issledovaniya. Profilakticheskaya meditsina 2013, 6: 25-34).
10. Shalnova SA, Conradi AO, Karpov YuA, et al. Cardiovascular mortality in 12 Russian federation regions - participants of the “Cardiovascular disease epidemiology in Russian regions” study. Russ J Cardiol 2012; 5 (97): 6-11. Russian (Shal'nova S. A., Konradi A. O., Karpov Yu. A. i dr. Analiz smertnosti ot serdechno-sosudistykh zabolevanii v 12 regionakh Rossiiskoi Federatsii, uchastvuyushchikh v issledovanii “Epidemiologiya serdechno-sosudistykh zabolevanii v razlichnykh regionakh Rossii”. Rossiiskii kardiologicheskii zhurnal 2012; 5 (97): 6-11).
11. Danaei G, Finucane MM, Lin JK. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5,4 million participants. Lancet 2011; 377, Issue 9765: 568-77.
12. Gu D, Reynolds K, Wu X, et al. Prevalence Awareness, Treatment, and Control of Hypertension in China. Hypertension 2002; 40: 920-7.
13. Grujić V, Dragnić N, Kvrgić S. Epidemiology of Hypertension in Serbia: Results of a National Survey. J Epidemiol 2012; 22 (3): 261-6.
14. Culter JA, Sorlie PD, Wolz M, et al. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999- 2004. J Hypertension 2008; 818-27.
15. Cheng S, Xanthakis V, Sullivan LM, et al. Blood pressure tracking over the adult life course: patterns and correlates in the Framingham study. Hypertension 2012; 60: 1393-9.
16. Dorobantu M, Darabont RO, Badila E, et al. Prevalence, Awareness, Treatment, and Control of Hypertension in Romania: Results of the SEPHAR Study. Int. J Hypertens 2010; Article ID 970694, 6 pages, https://doi.org/10,4061/2010/970694.
17. Wright JD, Hughes JP, Ostchega Y, et al. Mean Systolic and Diastolic Blood Pressure in Adults Aged 18 and Over in the United States, 2001-2008. National Center Health Statistics Reports 2011; 35: 24.
18. Morenoff JD, House JS, Hansen BB, et al. Understanding social disparities in hypertension prevalence, awareness, treatment, and control: The role of neighborhood context. Social Science & Medicine 2007; 65, Issue 9: 1853-66.
19. Bielecka-Dabrowa A, Aronow W, Rysz J, Banach M. The Rise and Fall of Hypertension: Lessons Learned from Eastern Europe. Curr Cardiovasc Risk Rep 2011; 5: 174-9.
20. Cifkova R, Skodova Z, Bruthans J, et al. Longitudinal trends in cardiovascular mortality and blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2007/2008. J Hypertension 2010; 28 (11): 2196-203.
21. Joffres M, Falaschetti E, Gillespie C. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open 2013; 3: e003423. https://doi.org/10.1136/bmjopen-2013-003423.
22. Oganov RG, Timofeeva TN, Koltunov IE, et al. Arterial hypertension epidemiology in Russia. The results of 2003-2010 Federal monitoring. Cardiovascular Therapy and Prevention 2011; 10 (1): 9-13. Russian (Oganov R. G., Timofeeva T. N., Koltunov I.E. i dr. Epidemiologiya arterial'noi gipertonii v Rossii. Rezul'taty federal'nogo monitoringa 2003-2010 gg. Kardiovaskulyarnaya terapiya i profilaktika 2011; 10 (1): 9-13).
23. Reklaitiene R, Tamosiunas A, Virviciute D, et al. Trends in prevalence, awareness, treatment, and control of hypertension, and the risk of mortality among middle-aged Lithuanian urban population in 1983-2009 BMC Cardiovascular Disorders 2012, 12: 68 http://www.biomedcentral.com/1471-2261/12/68.
24. Robitaille S, Dai S, Waters C. Diagnosed hypertension in Canada: incidence, prevalence and associated mortality. CMAJ 2012; 184 (1): E 49-56.
25. Levy D, Larson MG, Vasan RS, et al. The progression from hypertension to congestive heart failure. JAMA 1996; 275: 1557-62.
26. Boĭtsov SA, Filippov EV, Shal’nova SA, et al. Risk factors for noncommunicable diseases in the Ryazan Region (according to the data of the MERIDIAN-RU trial as the ESSE-RF pilot project). Preventive Medicine 2013; 6: 48-54. Russian (Boitsov S.A., Filippov E.V., Shal'nova S.A. i dr. Faktory riska neinfektsionnykh zabolevanii naseleniya Ryazanskoi oblasti (po dannym issledovaniya MERIDIAN-RO kak pilotnogo proekta issledovaniya ESSE-RF). Profilakticheskaya meditsina 2013; 6: 48-54).
27. McAlister FA, Wilkins K, Joffres M, et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ 2011; 183 (9): 1007-13.
28. Meng XJ, Dong GH, Wang D, et al. Prevalence, awareness, treatment, control, and risk factors associated with hypertension in urban adults from 33 communities of China: the CHPSNE study. J Hypertens 2011; 29 - Issue 7: 1303-10.
29. Shalnova SA, Deev AD, Vihireva OV, et al. The prevalence of hypertension in Russia. Awareness, treatment and control. Profilaktika zabolevanij i ukreplenie zdorov’ja 2001; 2: 3-7. Russian (Shal'nova S.A., Deev A. D., Vikhireva O.V. i dr. Rasprostranennost' arterial'noi gipertonii v Rossii. Informirovannost', lechenie, kontrol'. Zh Prof zabol ukrep zdorov'ya 2001; 2: 3-7).
30. Kayima J, Wanyenze RK, Katamba A, et al. Hypertension awareness, treatment and control in Africa: a systematic review. BMC Cardiovascular Disorders 2013; 13: 54 http://www.biomedcentral.com/1471-2261/13/54.
31. Gu Q, Burt VL, Dillon CF, Yoon S. Trends in Antihypertensive Medication Use and Blood Pressure Control Among United States adults With Hypertension: The National Health and Nutrition Examination Survey, 2001 to 2010. Circulation 2012; 126: 2105-14.
32. Wu X, Huxley R, Li L, et al. Prevalence awareness, treatment and control of hypertension in China: Data from the China National Nutrition and Health Survey 2002. Circulation 2008; 118: 2679-86.
33. Tocci G, Rosei EA, Ambrosioni E, et al. Blood pressure control in Italy: analysis of clinical data from 2005-2011 surveys on hypertension. J Hypertens 2012; 30 (6):1065-74.
34. Schäfer HH, Sudano I, Theus GR, et al. Target blood pressure attainment with antihypertensive therapy in Swiss primary care. Blood Pressure 2012; 21 (4): 211-9.
35. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-52.
36. Llisterri JL, Rodriguez-Roca GC, Escobar C, et al. Treatment and blood pressure control in Spain during 2002-2010. J Hypertens 2012; 30, Issue 12: 2425-31.
37. Campbell N, Young ER, Drouin D, et al. A Framework for Discussion on How to Improve Prevention, Management, and Control of Hypertension in Canada. Canadian J Cardiology 2012; 28, Issue 3: 262-9.
38. McDonald M, Hertz RP, Unger AN, Lustik MB. Prevalence, Awareness, and Management of Hypertension, Dyslipidemia, and Diabetes Among United States Adults Aged 65 and Older. Journal of Gerontology: MEDICAL SCIENCES cite journal as: J Gerontol A Biol Sci Med Sci 2009; 64A (2): 256-63.
39. Mancia G, Ambrosioni E, Rosei EA, et al. Blood pressure control and risk of stroke in untreated and treated hypertensive patients screened from clinical practice: results of the ForLife study. J Hypertens 2005; 23: 1575-81.
40. Ezzati M, Oza S, Danaei G, Murray CJ. Trends and cardiovascular mortality effects of state-level blood pressure and uncontrolled hypertension in the United States. Circulation 2008; 117: 905-14.
41. Malyszko J, Muntner P, Rysz J. Blood Pressure Levels and Stroke: J-curve Phenomenon? Curr Hypertens Rep 2013; 15: 575-81.
42. Grassi G, Cifkova R, Laurent S, et al. Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE study. Eur Heart J 2011; 32: 218-25.
Review
For citations:
Boytsov S.A., Balanova Yu.A., Shalnova S.A., Deev A.D., Artamonova G.V., Gatagonova T.M., Duplyakov D.V., Efanov A.Yu., Zhernakova Yu.V., Konradi A.O., Libis R.A., Minakov A.V., Nedogoda S.V., Oshchepkova E.V., Romanchuk S.A., Rotar O.P., Trubacheva I.A., Chazova I.E., Shlyakhto E.V., Muromtseva G.A., Evstifeeva S.E., Kapustina A.V., Konstantinov V.V., Oganov R.G., Mamedov M.N., Baranova E.I., Nazarova O.A., Shutemova O.A., Furmenko G.I., Babenko N.I., Azarin O.G., Bondartsov L.V., Khvostikova A.E., Ledyaeva A.A., Chumachek E.V., Isaeva E.N., Basyrova I.R., Kondratenko V.Yu., Lopina E.A., Safonova D.V., Skripchenko A.E., Indukaeva E.V., Cherkass N.V., Maksimov S.A., Danilchenko Ya.V., Mulerova T.A., Shalaev S.V., Medvedeva I.V., Shava V.G., Storozhok M.A., Tolparov G.V., Astakhova Z.T., Toguzova Z.A., Kaveshnikov V.S., Karpov R.S., Serebryakova V.N. ARTERIAL HYPERTENSION AMONG INDIVIDUALS OF 25–64 YEARS OLD: PREVALENCE, AWARENESS, TREATMENT AND CONTROL. BY THE DATA FROM ECCD. Cardiovascular Therapy and Prevention. 2014;13(4):4-14. (In Russ.) https://doi.org/10.15829/1728-8800-2014-4-4-14
ISSN 2619-0125 (Online)